Article Text

Download PDFPDF

Risedronate induced BOOP complicated with sarcoidosis
Free
  1. T Arai,
  2. Y Inoue,
  3. S Hayashi,
  4. S Yamamoto,
  5. M Sakatani
  1. National Hospital Organization Kinki-chuo Chest Medical Center, Sakai, Japan
  1. Correspondence to:
    Dr Y Inoue
    National Hospital Organization Kinki-chuo Chest Medical Center, 1180 Nagasone-cho, Sakai City, Osaka 591-8555, Japan; giichikch.hosp.go.jp

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Bisphosphonates are synthetic compounds that are taken up preferentially by skeletal tissue and suppress osteoclast mediated bone resorption. They are being used increasingly in the treatment of osteoporosis.1 Bronchoconstriction caused by bisphosphonates has been described2 but drug induced pneumonitis has not previously been reported.3 This is the first report of interstitial pneumonia induced by the bisphosphonate risedronate.

A woman developed an intramuscular mass in her right arm at the age of 51 years. Sarcoidosis was diagnosed by non-necrotising epithelioid granulomas in the resected specimen of the mass, bilateral hilar lymphadenopathy on the chest radiograph, a negative reaction to tuberculin test, and an increase in the serum angiotensin converting enzyme (ACE) level to 27.9 U/ml. She had pain in her right …

View Full Text